Long term efficacy and safety of patients with Ankylosing spondylitis treated with etanercept for 5 years: Analysis of different types of response

被引：0
|
作者：
Baraliakos, Xenofon [1 ]
Listing, J. [2 ]
Fritz, C. [2 ]
Song, In-Ho [3 ]
Haibel, H. [3 ]
Heldmann, F. [1 ]
Rudwaleit, M. [3 ]
Sieper, J. [3 ]
Braun, Juergen [1 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] German Rheumatism Res Ctr, Berlin, Germany
[3] Charite, Berlin, Germany
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S357 / S357
页数：1
相关论文
共 50 条
  • [21] LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF THE GO-RAISE TRIAL
    Deodhar, A.
    Braun, J.
    Inman, R.
    van der Heijde, D.
    Zhou, Y.
    Hsu, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 283 - 284
  • [22] RENAL SAFETY OF LONG TERM NSAID USE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Kim, Y. E.
    Park, S. Y.
    Ahn, S. M.
    Hong, S.
    Lee, C. K.
    Yoo, B.
    Oh, J. S.
    Kim, Y. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 618 - 619
  • [23] LONG-TERM EFFICACY AND SAFETY OF TNF INHIBITORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: A SINGLE CENTRE EXPERIENCE
    Bahtiyar, Toz
    Murat, Erdugan
    Emin, Oguz
    Bahar, Artim-Esen
    Burak, Erer
    Sevil, Kamali
    Ahmet, Gul
    Murat, Inanc
    Lale, Ocal
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 45 - 45
  • [24] Baseline factors influential on ASAS 20 response in ankylosing spondylitis patients treated with etanercept (ENBREL®)
    Davis, JC
    van der Heijde, DM
    Dougados, M
    Braun, J
    Cush, JJ
    Clegg, DO
    Inman, RD
    Devries, T
    Tsuji, WH
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S440 - S440
  • [25] Health consumption and costs reduction in patients with ankylosing spondylitis (AS) treated with etanercept (ETA) for 2 years.
    Benhamou, Mathilde
    Kolta, Sami
    Briot, Karine
    Roux, Christian
    Dougados, Maxime
    Fautrel, Bruno
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S718 - S719
  • [26] LONG-TERM SAFETY AND EFFICACY OF GOLIMUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS THROUGH 5 YEARS OF A RANDOMIZED, PLACEBO- CONTROLLED TRIAL
    Deodhar, Atul
    Braun, Jurgen
    Inman, Robert
    van der Heijde, Desiree
    Zhou, Yiying
    Hsu, Ben
    RHEUMATOLOGY, 2014, 53 : 142 - 142
  • [27] LONG-TERM EFFICACY AND SAFETY OF ARTHROTEC IN PATIENTS WITH RHEUMATOID-ARTHRITIS, OSTEOARTHRITIS OR ANKYLOSING-SPONDYLITIS
    KOCHMAN, RL
    GEIS, GS
    GAGNIER, RP
    STEAD, H
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 179 - 179
  • [28] Long-Term Safety and Efficacy of Etanercept in Patients with Moderate-to-Severe Psoriasis: 5-Years Data Experience
    Conti, Andrea
    Galdo, Giovanna
    Greco, Maurizio
    Borsari, Stefania
    Lasagni, Claudia
    CLINICAL DRUG INVESTIGATION, 2013, 33 : S84 - S86
  • [29] Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years-early clinical response predicts long-term outcome
    Baraliakos, Xenofon
    Listing, Joachim
    Fritz, Claudia
    Haibel, Hildrun
    Alten, Rieke
    Burmester, Gerd-Ruediger
    Krause, Andreas
    Schewe, Stefan
    Schneider, Matthias
    Soerensen, Helmut
    Schmidt, Reinhold
    Sieper, Joachim
    Braun, Juergen
    RHEUMATOLOGY, 2011, 50 (09) : 1690 - 1699
  • [30] Radiographic results from a long-term multicenter trial of etanercept (ENBREL®) in patients with ankylosing spondylitis
    van der Horst-Bruinsma, I.
    Wanders, A.
    van der Heijde, D.
    Fatenejad, S.
    RHEUMATOLOGY, 2006, 45 : I5 - I5
12345